KROS Keros Therapeutics - keith regnante resigns as CFO effective August 3, 2026 - SEC filing - Appoints annita tanini interim Principal fin

KROS Keros Therapeutics - keith regnante resigns as CFO effective August 3, 2026 - SEC filing - Appoints annita tanini interim Principal financial officer effective August 4, 2026 - SEC filing